Brought to you by 
Series B round brings in $15.5mm for Nodality
21 Apr 2010
Executive Summary
Nodality Inc. (personalized diagnostics) raised $15.5mm through the closing of its Series B round that initially opened in 2008. Returning investor Pfizer Ventures and Laboratory Corp. of America Holdings led and were joined by additional existing backers Kleiner Perkins Caufield & Byers, TPG Biotechnology, and Maverick Capital.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B round brings in $15.5mm for Nodality
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice